The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans, including those on Medicare.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com

















